![George A. Skouras](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de George A. Skouras
Sociétés | Poste | Début | Fin |
---|---|---|---|
Cue Capital LP
![]() Cue Capital LP Investment ManagersFinance Cue Capital LP engages in the provision of strategic fund raising for fund management teams. It offers discovery meetings, due diligence, strategic consulting, and fundraising. The company was founded by George Skouras in 2003 and is headquartered in New York, NY. | Directeur Général | 01/01/2003 | - |
Fondateur | 01/01/2003 | - | |
Olatec Therapeutics LLC
![]() Olatec Therapeutics LLC Pharmaceuticals: MajorHealth Technology Olatec Therapeutics LLC is a privately held biopharmaceutical company based in the United States. The American company is in the clinical stage of developing a platform of oral NLRP3 inhibitors to treat and prevent a broad spectrum of acute and chronic inflammatory diseases mediated by IL-1. Olatec's proprietary compounds include approximately 60 analogues being screened as viable drug candidates, and the company has over 140 patents granted covering its compounds. The company's drug development team is comprised of experienced management and international experts in translational medicine with unparalleled expertise in inflammation and immunology. Olatec is conducting clinical trials in the FDA and EMA. The company was founded by Damaris B. Skouras, who has been the CEO since incorporation. | Directeur/Membre du Conseil | - | - |
Historique de carrière de George A. Skouras
Statistiques
Internationale
Etats-Unis | 3 |
Opérationnelle
Chief Executive Officer | 1 |
Founder | 1 |
Director/Board Member | 1 |
Sectorielle
Finance | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Cue Capital LP
![]() Cue Capital LP Investment ManagersFinance Cue Capital LP engages in the provision of strategic fund raising for fund management teams. It offers discovery meetings, due diligence, strategic consulting, and fundraising. The company was founded by George Skouras in 2003 and is headquartered in New York, NY. | Finance |
Olatec Therapeutics LLC
![]() Olatec Therapeutics LLC Pharmaceuticals: MajorHealth Technology Olatec Therapeutics LLC is a privately held biopharmaceutical company based in the United States. The American company is in the clinical stage of developing a platform of oral NLRP3 inhibitors to treat and prevent a broad spectrum of acute and chronic inflammatory diseases mediated by IL-1. Olatec's proprietary compounds include approximately 60 analogues being screened as viable drug candidates, and the company has over 140 patents granted covering its compounds. The company's drug development team is comprised of experienced management and international experts in translational medicine with unparalleled expertise in inflammation and immunology. Olatec is conducting clinical trials in the FDA and EMA. The company was founded by Damaris B. Skouras, who has been the CEO since incorporation. | Health Technology |
- Bourse
- Insiders
- George A. Skouras
- Expérience